Blood Pressure Drugs Prevent More Heart Events Than Falls

A November 2026 Nature Communications study found antihypertensive treatment prevents more serious cardiovascular events than it causes falls.

Updated on Nov. 20, 2026 in Heart Disease

Plain amber pill bottles with unlabeled white caps beside a folded blood pressure cuff on pale marble under soft window light.
A November 2026 study in Nature Communications found blood pressure medication prevented more serious heart events than it caused falls across 5.6 million patients aged 40 and older. AI Illustration. Upload story photo >

Live Poll

Do you trust your doctor to weigh medication benefits against risks for you?

A study published in Nature Communications in November 2026 found that antihypertensive treatment prevented more serious cardiovascular events than it caused falls. The analysis drew on data from 5,578,002 patients aged 40 and older in the Clinical Practice Research Datalink.

Why it matters

The findings give clinicians a risk-versus-benefit estimate for blood pressure medication across a large patient population. They suggest that for many patients the chance of preventing a heart attack or stroke outweighs the risk of serious harm such as falls.

The STRATIFY-CVD model compared absolute benefits against absolute harms across 5,578,002 patients from 1998 to 2018, with 6.6% of the validation cohort experiencing a CVD event over 10 years. The model's applicability to patients outside the dataset is not addressed in the source.

The players

Nature Communications

Nature Communications is an open-access, peer-reviewed scientific journal published by the Nature Portfolio that covers research across the natural sciences.

University of Oxford

The University of Oxford is a public research university in England and one of the oldest universities in the world, with a strong tradition in clinical and population health research.

The details

Researchers built a clinical prediction model called STRATIFY-CVD and compared the absolute benefits of treatment with the absolute risk of harm. The model found more patients were estimated to be at high risk of cardiovascular disease than at risk of serious adverse events such as hypotension, syncope, falls, fracture and acute kidney injury.

Timeline

  1. 1998 to 2018: Period of patient data examined in the study.

  2. November 2026: Study published in Nature Communications.

  3. 10-year follow-up: Window in which cardiovascular events were tracked in the validation cohort.

Health Landscape

The study extends the benefit-versus-harm framing used in large cardiovascular trials such as ORION-10 to blood pressure medication in routine primary care records. It shows how population-scale observational data can inform treatment decisions for a common chronic condition.

For people already prescribed blood pressure medication, the findings suggest the likelihood of preventing serious heart events generally outweighs the risk of falls over a decade. Decisions about starting or continuing treatment remain a matter for patients and their clinicians.

The takeaway

Benefit-versus-harm estimates from large patient datasets can help patients and clinicians weigh blood pressure treatment more concretely. Discuss your individual cardiovascular risk and medication side effects with your healthcare provider.

Further reading

Explore more on Heart Disease for context on cardiovascular risk and treatment.

Source note: This article includes information reported by McKnight's Long-Term Care News.

Live Poll

Do you trust your doctor to weigh medication benefits against risks for you?